Vyome Therapeutics Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials and compliance.
CIN U73100GJ2017PLC098900 Incorporated 30 August 2017 ROC Ahmedabad HQ Vadodara, Gujarat, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹3.35 Cr
▼ 12.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.11 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
6
Latest available

About Vyome Therapeutics Limited

Data last updated: 10 February 2026

Vyome Therapeutics Limited is a public limited company based in Vadodara, Gujarat, India, a subsidiary of Vyome Therapeutics Inc. , Usa. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 30 August 2017, the company has been in operation for over 9 years.

Registered with ROC Ahmedabad under CIN U73100GJ2017PLC098900.

Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.11 Lakh. It is led by directors including Raghunath Anant Mashelkar and Ranjana Kumar.

Last AGM: 27 September 2025. Financial statements filed for year ended 31 March 2025. Office: C4 – 201 Akshar Pavilion Priya Cinema Road, Vadodara, Gujarat, India – 390021.

As per the financials filed for FY 2025, the company reported a revenue of ₹3.35 Cr, a decline of 12% compared to the previous year.

The company has a workforce of approximately 6 employees as per the latest available data. It operates as a subsidiary of Vyome Therapeutics Inc. , Usa.

The company is associated with 1 brand - Vyome Therapeutics.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vyometx.com.

Company Details of Vyome Therapeutics Limited
CIN U73100GJ2017PLC098900
Registration Number 098900
Incorporation Date 30 August 2017
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Vyome Therapeutics Inc. , Usa
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    C4 – 201 Akshar Pavilion Priya Cinema Road, Vadodara, Gujarat, India – 390021
  • Industry
    Pharma, Pharma Contract R&D
Company report
Vyome Therapeutics Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Vyome Therapeutics Limited report

Financials, compliance, directors, charges, ownership and filings for Vyome Therapeutics Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Vyome Therapeutics Limited

Vyome Therapeutics Limited operates one associated brand: Vyome Therapeutics. These brands represent Vyome Therapeutics Limited's diversified market presence and brand portfolio.

Brand Description Website
Small molecule therapeutics for immuno-inflammatory conditions are developed. vyometx.com

Competitors & Alternatives of Vyome Therapeutics Limited

Brands and companies operating in the same space as Vyome Therapeutics Limited include Revance Therapeutics, Annexon, MeiraGTx and 7 more.

Competitor Description Location Founded
Revance  Therapeutics Revance Therapeutics Neurotoxin products for aesthetic and therapeutic skin treatments are developed. Newark, United States, United States 2002
Annexon Annexon Developer of antibodies to treat complement-mediated neurodegenerative diseases San Francisco, United States, United States 2011
MeiraGTx MeiraGTx Gene therapies for ocular and neurodegenerative diseases are developed. New York, United States, United States 2015
Aldeyra Aldeyra Drug candidates for immune-mediated diseases are developed by Aldeyra. Lexington, United States, United States 2004
Nicox Nicox Nitric oxide-based therapeutics for glaucoma and eye conditions are developed. Valbonne, France, France 1996
Dermavant Dermavant Small molecule therapeutics for inflammatory skin diseases are developed. Phoenix, United States, United States 2016
GenSight Biologics GenSight Biologics Viral vector-based gene therapies for retinal diseases are developed. Paris, France, France 2011
Sol-Gel Technologies Sol-Gel Technologies Developing topical drug products for the treatment of rosacea, acne and interdigital tinea pedis. United States 1998
SkinMedica SkinMedica Skin care products are developed and manufactured by SkinMedica. Carlsbad, United States, United States 1999
Gyroscope Gyroscope Mobile SDK developed for app engagement and monetization strategies. San Francisco, United States, United States 2016

Business Activity of Vyome Therapeutics Limited

Vyome Therapeutics Limited is engaged in principal business activities including professional, scientific and technical and trade, with detailed activities including other professional, scientific and technical activities, wholesale trading. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M9 Other professional, scientific and technical activities Locked
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Vyome Therapeutics Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Vyome Therapeutics Limited

Vyome Therapeutics Limited is audited by SAXENA & SAXENA for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
SAXENA & SAXENA Locked Locked Locked
Premium access

Complete auditor history for Vyome Therapeutics Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Vyome Therapeutics Limited

Vyome Therapeutics Limited is currently managed by 5 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Raghunath Anant Mashelkar Director 09 Feb 2019 7 Years 5 Months Current
Ranjana Kumar Director 09 Feb 2019 7 Years 5 Months Current
Sivaram Swaminathan Director 09 Feb 2019 7 Years 5 Months Current
Shiladitya Sengupta Director 30 Aug 2017 8 Years 10 Months Current
Venkateswarlu Nelabhotla Director 30 Aug 2017 8 Years 10 Months Current

Financials of Vyome Therapeutics Limited FY 2025 filings available

Vyome Therapeutics Limited reported revenue of ₹3.35 Cr (down 12.00% YoY) for FY 2025.

Revenue · FY 2025
₹3.35 Cr ▼ 12.00%
Premium access

Ten-year financial statements for Vyome Therapeutics Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Vyome Therapeutics Limited

Premium access

Shareholding and ownership data for Vyome Therapeutics Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Vyome Therapeutics Limited

Vyome Therapeutics Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Vyome Therapeutics Limited

Vyome Therapeutics Limited has a workforce of 6 employees as of Mar 30, 2024.

Employee count
6
Active EPFO establishments
1
Employee growth
-25%
Premium access

Employee and EPFO history for Vyome Therapeutics Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Vyome Therapeutics Limited

Premium access

GST registrations and filing compliance for Vyome Therapeutics Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Vyome Therapeutics Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Vyome Therapeutics Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Vyome Therapeutics Limited

Premium access

MSME payment history for Vyome Therapeutics Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Vyome Therapeutics Limited

Premium access

Corporate group structure for Vyome Therapeutics Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Vyome Therapeutics Limited

Premium access

MCA filings and documents for Vyome Therapeutics Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Vyome Therapeutics Limited

Activity
27 Sep 2025
Vyome Therapeutics Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Vyome Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Directors
09 Feb 2019
Raghunath Anant Mashelkar was appointed as a Director on 09 Feb 2019 & has been associated with this company since 7 years 5 months.
Directors
09 Feb 2019
Ranjana Kumar was appointed as a Director on 09 Feb 2019 & has been associated with this company since 7 years 5 months.
Directors
09 Feb 2019
Sivaram Swaminathan was appointed as a Director on 09 Feb 2019 & has been associated with this company since 7 years 5 months.
Directors
30 Aug 2017
Shiladitya Sengupta was appointed as a Director on 30 Aug 2017 & has been associated with this company since 8 years 10 months.

Frequently Asked Questions about Vyome Therapeutics Limited

Vyome Therapeutics Limited is an active public limited company in the pharma sector based in Vadodara, Gujarat, India. It was incorporated on 30 August 2017 (9+ years old) and is registered under CIN U73100GJ2017PLC098900. The company has 6 employees.

Vyome Therapeutics Limited reported revenue of ₹3.35 Cr for FY 2025 (down 12.00% YoY).

The current directors of Vyome Therapeutics Limited are:

The primary industry of Vyome Therapeutics Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Vyome Therapeutics Limited can be reached at the registered office: C4 – 201 Akshar Pavilion Priya Cinema Road, Vadodara, Gujarat, India – 390021, or through the website vyometx.com.

The authorised capital is ₹5 Lakh, and the paid-up capital is ₹1.11 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available